ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Holland Recovering From Coronary Bypass; Henry Kaplan Receives Annual Prentis Award

July 25, 1980

NTP Board Approves Concept For New Mutagenesis Assays

January 1, 1988

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

Two View Mammography Said Less Costly Than One In Screening

April 25, 1986

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

April 3, 1998

NCI’s Supercomputer Undergoing Testing

April 11, 1986